Philip Morris International is evaluating the sale of its US cigar business, a move aligning with its major transition towards smoke-free offerings, which may have driven its shares up 20% over the last quarter. This potential divestiture shows the company's continued commitment to evolving its portfolio, resonating positively with investors, especially as broader market sentiment shows lingering economic concerns. Within the same quarter, the company's earnings report revealed a significant net loss compared to the previous year, yet consistent sales growth provided a silver lining. The reaffirmation of earnings guidance for 2025 further emphasized its confidence, possibly supporting its share price during this uncertain period. Meanwhile, the broader market broadly decreased 1%, reflecting investor unease and external economic pressures, but Philip Morris's dedicated push towards future-focused products likely cushioned its stocks against the overall market downturns.

Dig deeper into the specifics of Philip Morris International here with our thorough analysis report.

Over the last five years, Philip Morris International's total shareholder return, including dividends, reached 149.40%. This performance reflects a combination of strategic adjustments and market movements. Key developments include the potential sale of the US cigar business, which echoes the company's pivot towards smoke-free products. This was complemented by higher quarterly dividends announced in 2024, indicating shareholder value focus even amidst a backdrop of fluctuating profit margins. Moreover, the company's revenue growth, with full-year 2024 sales rising to US$37.88 billion from US$35.17 billion, exhibits steady demand, despite recent financial volatility.

Relative to the US Market and Tobacco industry, Philip Morris outperformed significantly over the past year, signaling investor confidence in its long-term strategic shifts. The company's capacity for resilience was further highlighted by its ability to secure a €1.5 billion credit facility in December 2024, earmarked for maintaining operational liquidity. Additionally, ongoing innovations like the launch of the IQOS ILUMA i device underscore Philip Morris's continued transformation efforts, aiming to enhance its product portfolio and future prospects.

• Unlock the insights behind Philip Morris International's valuation and discover its true investment potential
• Analyze the downside risks for Philip Morris International and understand their potential impact—click to learn more.
• Is Philip Morris International part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NYSE:PM.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com